Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04673032 · ClinicalTrials.gov registry record
Radiofrequency (RF) Ablation Prospective Outcomes Study
A clinical trial of Pain, Chronic, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 298
- Enrollment target
- 15
- Study locations
NCT04673032: Completed study of Pain, Chronic, sponsored by Boston Scientific Corporation.
NCT04673032 is a study of Pain, Chronic that has completed, run by Boston Scientific Corporation. The registered enrollment target is 298 participants, below the 715-participant average among 48 other Pain, Chronic trials with a reported enrollment target (58% lower). The trial reports 15 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04673032, a study of Pain, Chronic, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 298 participants
- Enrollment target
- 15
- Study locations
Study Summary
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain
Primary Outcome
Using the Patient Global Impression of Change (PGIC) Scale, subjects will rate themselves as: very much improved; much improved; minimally improved; no change; minimally worse; much worse; or very much worse compared with Baseline
Conditions Studied
Interventions
- DEVICE Radiofrequency Ablation
Study Locations (15)
Other
- ZNA Hoge Beuken - Antwerp
- St. Jan - Bruges
- Mater Olbia Hospital - Olbia
- St. Anna Hospital - Geldrop
Ohio
- UC Health Pain Medicine - Cincinnati
- Premier Pain Treatment Institute - Loveland
- Toledo Clinic - Toledo
Arizona
- Elite Pain and Spine Institute - Mesa
- Tucson Orthopaedic Institute - Tucson
Connecticut
- The Spine Wellness Center in Westport - Westport
Georgia
- Shepherd Center - Atlanta
Illinois
- Quincy Medical Group - Quincy
Minnesota
- Twin Cities Pain Clinic and Surgery Center - Edina
North Carolina
- Carolinas Research Institute - Huntersville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2020-12-22 |
| Est. Completion | 2025-02-07 |
What the finished NCT04673032 record still lists
NCT04673032 is an observational study that tracks outcomes without assigning an intervention. The registered 298 participants enrollment target is mid-sized for trials with a published cap, below the 715-participant average among 48 other Pain, Chronic trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Pain, Chronic appearing as the primary indexed condition, and to 1 intervention - of which Radiofrequency Ablation is the first listed.
NCT04673032 lists 15 locations in 9 states (Other, Ohio, Arizona).
Frequently Asked Questions
What is clinical trial NCT04673032 about?
NCT04673032 is a clinical study titled "Radiofrequency (RF) Ablation Prospective Outcomes Study". The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain
What is the current status of trial NCT04673032?
This trial is currently completed. The enrollment target is 298 participants. The study started on 2020-12-22. Estimated completion is 2025-02-07.
What conditions does trial NCT04673032 study?
This clinical trial studies the following conditions: Pain, Chronic.
What interventions are being tested in trial NCT04673032?
The interventions under investigation include: Radiofrequency Ablation (DEVICE).
Who is sponsoring clinical trial NCT04673032?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04673032 being conducted?
This trial has 15 study locations across Arizona, Connecticut, Georgia, Illinois, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04673032's enrollment target sits among peer trials
298 12th of 48 higher than 37 of 48 other Pain, Chronic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Chronic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
RECRUITING · NA
-
Pain and Weight Treatment: Development and Trial of PAW
RECRUITING · NA
-
VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
RECRUITING · Phase 2
-
Pain Reprocessing Therapy in Post-Operative Knee Pain
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06305624 · 298 participants · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
- NCT06754215 · 298 participants · NA
Smoking Cessation Intervention Development for Homeless Youth
- NCT06780111 · 298 participants · Phase 1
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
- NCT07209358 · 298 participants · NA
EDX110 Randomized Control Trial for Treatment of DFUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI